Skip to main content
Erschienen in: Journal of Assisted Reproduction and Genetics 11/2019

17.10.2019 | Genetics

Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion

verfasst von: Deepika Delsa Dean, Sarita Agarwal, Srinivasan Muthuswamy

Erschienen in: Journal of Assisted Reproduction and Genetics | Ausgabe 11/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Recurrent spontaneous abortion is a multifactorial disorder and till date, various factors have been attributed in its pathogenesis. Still, approximately 50% of RSA cases remain unexplained. Premutation (PM) expanded allele of fragile-X mental retardation 1 (FMR1) gene is known to contribute to ovarian dysfunction in 20% of the cases. Recently, the link between expanded FMR1 allele and recurrent miscarriages has been reported.

Method

In the present prospective case–control study, we have investigated the status of CGG repeat size at 5′UTR of the FMR1 gene in women with unexplained RSA in comparison to age-matched healthy control women (n = 100 each). The genomic DNA from these samples was subjected to molecular analysis for characterization of CGG repeat size and composition at FMR1 gene

Results

As compared to the control women, the RSA women cohort had a higher frequency of carriers with alleles in gray zone (GZ) and expanded PM range, i.e., 2% (2/100) versus 5% (5/100), respectively. Also, the RSA cohort had a significantly higher number of normal alleles with ≥ 35 CGG repeats (24 out of 200 alleles) as compared to control cohort (8 out of 200 alleles). The number of larger FMR1 alleles with pure CGG repeat tract was found to be significantly higher (P = 0.0063) in the RSA cohort (15 out of 200 alleles) as compared to that in control cohort (3 out of 200 alleles).

Conclusion

Henceforth, the CGG expanded uninterrupted FMR1 allele might be associated with recurrent abortions and may help to explain many of these unexplained cases.
Literatur
2.
Zurück zum Zitat Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top Guideline No. 17. Royal College of Obstetricians and Gynaecologists (RCOG), 2011. Royal College of Obstetricians and Gynaecologists (RCOG). The investigation and treatment of couples with recurrent first-trimester and second-trimester miscarriage. Green-top Guideline No. 17. Royal College of Obstetricians and Gynaecologists (RCOG), 2011.
3.
Zurück zum Zitat Practice Committee of the American Society for Reproductive Medicine, 2012Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98: 1103–1111 Practice Committee of the American Society for Reproductive Medicine, 2012Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012; 98: 1103–1111
4.
Zurück zum Zitat Ali O, Hakimi I, Chanana A, et al. Grossesse sur utérus cloisonné menée à terme: à propos d’un cas avec revue de la literature. The Pan African Medical Journal. 2015;22:219.PubMedPubMedCentral Ali O, Hakimi I, Chanana A, et al. Grossesse sur utérus cloisonné menée à terme: à propos d’un cas avec revue de la literature. The Pan African Medical Journal. 2015;22:219.PubMedPubMedCentral
5.
Zurück zum Zitat Cohn DM, Goddijn M, Middeldorp S, et al. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010;8:2208–13.PubMedCrossRef Cohn DM, Goddijn M, Middeldorp S, et al. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thromb Haemost. 2010;8:2208–13.PubMedCrossRef
6.
Zurück zum Zitat Srinivas SK, Ma Y, Sammel MD, Chou D, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195:797–802.PubMedCrossRef Srinivas SK, Ma Y, Sammel MD, Chou D, et al. Placental inflammation and viral infection are implicated in second trimester pregnancy loss. Am J Obstet Gynecol. 2006;195:797–802.PubMedCrossRef
7.
Zurück zum Zitat Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med. 2006;24:33–9.PubMedCrossRef Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med. 2006;24:33–9.PubMedCrossRef
8.
Zurück zum Zitat Pluchino N, Drakopoulos P, Wenger JM, Petignat P, et al. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314–22.CrossRef Pluchino N, Drakopoulos P, Wenger JM, Petignat P, et al. Hormonal causes of recurrent pregnancy loss (RPL). Hormones (Athens). 2014;13(3):314–22.CrossRef
9.
Zurück zum Zitat Niroumanesh S, Mehdipour P, Farajpour A, Darvish S. A cytogenetic study of couples with repeated spontaneous abortions. Ann Saudi Med. 2011;31:77–9.PubMedPubMedCentralCrossRef Niroumanesh S, Mehdipour P, Farajpour A, Darvish S. A cytogenetic study of couples with repeated spontaneous abortions. Ann Saudi Med. 2011;31:77–9.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Dubey S, Chowdhury MR, Prahlad B, Kumar V, Mathur R, et al. Cytogenetic causes for recurrent spontaneous abortions – an experience of 742 couples (1484 cases). Indian J Hum Genet. 2005;11:94–8.CrossRef Dubey S, Chowdhury MR, Prahlad B, Kumar V, Mathur R, et al. Cytogenetic causes for recurrent spontaneous abortions – an experience of 742 couples (1484 cases). Indian J Hum Genet. 2005;11:94–8.CrossRef
11.
Zurück zum Zitat Iravathy GK, Raina V, Verma S, Chadha G. Cytogenetics and genetic counselling of patients in North India. J K Science. 2006;8:28–30. Iravathy GK, Raina V, Verma S, Chadha G. Cytogenetics and genetic counselling of patients in North India. J K Science. 2006;8:28–30.
12.
Zurück zum Zitat Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66(1):24–9.PubMedCrossRef Stephenson MD. Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril. 1996;66(1):24–9.PubMedCrossRef
13.
Zurück zum Zitat Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50(1):132–45.PubMedCrossRef Stephenson M, Kutteh W. Evaluation and management of recurrent early pregnancy loss. Clin Obstet Gynecol. 2007;50(1):132–45.PubMedCrossRef
14.
Zurück zum Zitat Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ, et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32 Epub 2010/02/27.PubMedCrossRef Toth B, Jeschke U, Rogenhofer N, Scholz C, Wurfel W, Thaler CJ, et al. Recurrent miscarriage: current concepts in diagnosis and treatment. J Reprod Immunol. 2010;85(1):25–32 Epub 2010/02/27.PubMedCrossRef
15.
Zurück zum Zitat Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012;67(4):341–7.PubMedCrossRef Daher S, Mattar R, Gueuvoghlanian-Silva BY, Torloni MR. Genetic polymorphisms and recurrent spontaneous abortions: an overview of current knowledge. Am J Reprod Immunol. 2012;67(4):341–7.PubMedCrossRef
16.
17.
Zurück zum Zitat Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.PubMedCrossRef Sullivan AK, Marcus M, Epstein MP, et al. Association of FMR1 repeat size with ovarian dysfunction. Hum Reprod. 2005;20(2):402–12.PubMedCrossRef
18.
Zurück zum Zitat Pastore LM, Young SL, Baker VL, Karns LB, Williams CD. Silverman LM Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012 Nov;19(11):1226–31.PubMedPubMedCentralCrossRef Pastore LM, Young SL, Baker VL, Karns LB, Williams CD. Silverman LM Elevated prevalence of 35-44 FMR1 trinucleotide repeats in women with diminished ovarian reserve. Reprod Sci. 2012 Nov;19(11):1226–31.PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464–70.PubMedCrossRef Streuli I, Fraisse T, Ibecheole V, Moix I, Morris MA, de Ziegler D. Intermediate and premutation FMR1 alleles in women with occult primary ovarian insufficiency. Fertil Steril. 2009;92(2):464–70.PubMedCrossRef
20.
Zurück zum Zitat Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009;91(5):1700–6.PubMedCrossRef Gleicher N, Weghofer A, Barad DH. A pilot study of premature ovarian senescence: I. Correlation of triple CGG repeats on the FMR1 gene to ovarian reserve parameters FSH and anti-Müllerian hormone. Fertil Steril. 2009;91(5):1700–6.PubMedCrossRef
21.
Zurück zum Zitat Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011;26(8):2077–83.PubMedCrossRef Karimov CB, Moragianni VA, Cronister A, Srouji S, Petrozza J, Racowsky C, et al. Increased frequency of occult fragile X-associated primary ovarian insufficiency in infertile women with evidence of impaired ovarian function. Hum Reprod. 2011;26(8):2077–83.PubMedCrossRef
22.
Zurück zum Zitat Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29:299–307.PubMedCrossRef Sullivan SD, Welt C, Sherman S. FMR1 and the continuum of primary ovarian insufficiency. Semin Reprod Med. 2011;29:299–307.PubMedCrossRef
23.
Zurück zum Zitat Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.PubMedPubMedCentralCrossRef Man L, Lekovich J, Rosenwaks Z, Gerhardt J. Fragile X-associated diminished ovarian reserve and primary ovarian insufficiency from molecular mechanisms to clinical manifestations. Front Mol Neurosci. 2017;10:290.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod. 1999;14:1217–8.PubMedCrossRef Murray A, Webb J, MacSwiney F, Shipley EL, Morton NE, Conway GS. Serum concentrations of follicle stimulating hormone may predict premature ovarian failure in FRAXA premutation women. Hum Reprod. 1999;14:1217–8.PubMedCrossRef
25.
Zurück zum Zitat Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23:1220–5.PubMedCrossRef Rohr J, Allen EG, Charen K, Giles J, He W, Dominguez C, et al. Anti-Mullerian hormone indicates early ovarian decline in fragile X mental retardation (FMR1) premutation carriers: a preliminary study. Hum Reprod. 2008;23:1220–5.PubMedCrossRef
26.
Zurück zum Zitat Harper PS, Jones L. Huntington's disease: genetic and molecular studies. In: Harper PS, Jones L, editors. Huntington’s disease, edited by Bates GP. Oxford, UK: Oxford University Press; 2002. p. 113–58. Harper PS, Jones L. Huntington's disease: genetic and molecular studies. In: Harper PS, Jones L, editors. Huntington’s disease, edited by Bates GP. Oxford, UK: Oxford University Press; 2002. p. 113–58.
27.
Zurück zum Zitat Dean DD, Agarwal S, Tripathi P. Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages. J Assist Reprod Genet. 2018;35(12):2121–8.PubMedPubMedCentralCrossRef Dean DD, Agarwal S, Tripathi P. Connecting links between genetic factors defining ovarian reserve and recurrent miscarriages. J Assist Reprod Genet. 2018;35(12):2121–8.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Bodega B, Bione S, Dalprà L, Toniolo D, Ornaghi F, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2005;21(4):952–7.PubMedCrossRef Bodega B, Bione S, Dalprà L, Toniolo D, Ornaghi F, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2005;21(4):952–7.PubMedCrossRef
29.
Zurück zum Zitat Lekovich J, Man L, Xu K, Canon C, Lilienthal D, et al. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genet Med. 2018;20(9):957–64.PubMedCrossRef Lekovich J, Man L, Xu K, Canon C, Lilienthal D, et al. CGG repeat length and AGG interruptions as indicators of fragile X-associated diminished ovarian reserve. Genet Med. 2018;20(9):957–64.PubMedCrossRef
30.
Zurück zum Zitat Srinivasan M, Dean DD, Agarwal S. Molecular screening of intellectually disabled and premature ovarian failure cases for CGG repeat expansion at FMR1 locus: implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis. Neurol India. 2016;64(6):1175–9.CrossRef Srinivasan M, Dean DD, Agarwal S. Molecular screening of intellectually disabled and premature ovarian failure cases for CGG repeat expansion at FMR1 locus: implication of combined triplet repeat primed polymerase chain reaction and methylation-specific polymerase chain reaction analysis. Neurol India. 2016;64(6):1175–9.CrossRef
31.
Zurück zum Zitat Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril. 2010;94(3):869–74.PubMedCrossRef Bibi G, Malcov M, Yuval Y, Reches A, Ben-Yosef D, et al. The effect of CGG repeat number on ovarian response among fragile X premutation carriers undergoing preimplantation genetic diagnosis. Fertil Steril. 2010;94(3):869–74.PubMedCrossRef
32.
Zurück zum Zitat Pastore LM, Christianson MS, McGuinness B, Vaught KC, et al. Does theFMR1 gene affect IVF success? Reprod BioMed Online. 2019;38(4):560–9.PubMedCrossRef Pastore LM, Christianson MS, McGuinness B, Vaught KC, et al. Does theFMR1 gene affect IVF success? Reprod BioMed Online. 2019;38(4):560–9.PubMedCrossRef
33.
Zurück zum Zitat Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376–82.PubMedCrossRef Bretherick KL, Fluker MR, Robinson WP. FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet. 2005;117:376–82.PubMedCrossRef
34.
Zurück zum Zitat Bodega B, Bione S, Dalpr’a L, Toniolo D, Ornaghi F, Vegetti W, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952–7.PubMedCrossRef Bodega B, Bione S, Dalpr’a L, Toniolo D, Ornaghi F, Vegetti W, et al. Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod. 2006;21:952–7.PubMedCrossRef
35.
Zurück zum Zitat Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000;97:189–94.PubMedCrossRef Sherman SL. Premature ovarian failure in the fragile X syndrome. Am J Med Genet. 2000;97:189–94.PubMedCrossRef
36.
Zurück zum Zitat Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef Te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8:141–54.CrossRef
37.
Zurück zum Zitat Watson MS, Breg WR, Pauls D, Brown WT, Carroll AJ, Howard-Peebles PN, et al. Aneuploidy and the fragile X syndrome. Am J Med Genet. 1988;30(1-2):115–21.PubMedCrossRef Watson MS, Breg WR, Pauls D, Brown WT, Carroll AJ, Howard-Peebles PN, et al. Aneuploidy and the fragile X syndrome. Am J Med Genet. 1988;30(1-2):115–21.PubMedCrossRef
38.
Zurück zum Zitat Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8:247–52.PubMedCrossRef Murray A, Ennis S, MacSwiney F, Webb J, Morton NE. Reproductive and menstrual history of females with fragile X expansions. Eur J Hum Genet. 2000;8:247–52.PubMedCrossRef
39.
Zurück zum Zitat Hundscheid RD, Smits AP, Thomas CM, Kiemeney LA, Braat DD. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet A. 2003;117A:6–9.PubMedCrossRef Hundscheid RD, Smits AP, Thomas CM, Kiemeney LA, Braat DD. Female carriers of fragile X premutations have no increased risk for additional diseases other than premature ovarian failure. Am J Med Genet A. 2003;117A:6–9.PubMedCrossRef
40.
Zurück zum Zitat Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef Allen EG, Sullivan AK, Marcus M, Small C, Dominguez C, Epstein MP, et al. Examination of reproductive aging milestones among women who carry the FMR1 premutation. Hum Reprod. 2007;22:2142–52.PubMedCrossRef
41.
Zurück zum Zitat Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril, 2000, vol. 74 (pg. 335-337)PubMedCrossRef Trout SW, Seifer DB. Do women with unexplained recurrent pregnancy loss have higher day 3 serum FSH and estradiol values? Fertil Steril, 2000, vol. 74 (pg. 335-337)PubMedCrossRef
42.
Zurück zum Zitat Gurbuz B, Yalti S, Ozden S, Ficicioglu C. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet. 2004;270:37–9.PubMedCrossRef Gurbuz B, Yalti S, Ozden S, Ficicioglu C. High basal estradiol level and FSH/LH ratio in unexplained recurrent pregnancy loss. Arch Gynecol Obstet. 2004;270:37–9.PubMedCrossRef
43.
Zurück zum Zitat Dean DD, Agarwal S, Kapoor D, Vati C. Molecular characterization of FMR1 gene in reproductive age women and premature ovarian insufficiency cases by TP-PCR. J mol Diagn Ther. 2017;22:91–100.CrossRef Dean DD, Agarwal S, Kapoor D, Vati C. Molecular characterization of FMR1 gene in reproductive age women and premature ovarian insufficiency cases by TP-PCR. J mol Diagn Ther. 2017;22:91–100.CrossRef
44.
Zurück zum Zitat Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod BioMed Online. 2009;19(2):281–6.PubMedCrossRef Chatterjee S, Maitra A, Kadam S, et al. CGG repeat sizing in the FMR1 gene in Indian women with premature ovarian failure. Reprod BioMed Online. 2009;19(2):281–6.PubMedCrossRef
45.
Zurück zum Zitat Kline J, Kinney A, Brown S, Levin B, Oppenheimer K, Warburton D. Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus. Hum Reprod. 2012;27(7):2224–32.PubMedCrossRefPubMedCentral Kline J, Kinney A, Brown S, Levin B, Oppenheimer K, Warburton D. Trisomic pregnancy and intermediate CGG repeat length at the FMR1 locus. Hum Reprod. 2012;27(7):2224–32.PubMedCrossRefPubMedCentral
Metadaten
Titel
Defining the role of FMR1 gene in unexplained recurrent spontaneous abortion
verfasst von
Deepika Delsa Dean
Sarita Agarwal
Srinivasan Muthuswamy
Publikationsdatum
17.10.2019
Verlag
Springer US
Erschienen in
Journal of Assisted Reproduction and Genetics / Ausgabe 11/2019
Print ISSN: 1058-0468
Elektronische ISSN: 1573-7330
DOI
https://doi.org/10.1007/s10815-019-01591-x

Weitere Artikel der Ausgabe 11/2019

Journal of Assisted Reproduction and Genetics 11/2019 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.